<DOC>
	<DOCNO>NCT02860299</DOCNO>
	<brief_summary>In VERROUREA study , two case abnormal increase TCA . In theory leakage lock bloodstream see . Lock leakage could particularly serious , especially clinical , repercussion patient already high risk haemorrhage give numerous associate comorbidities . The aim study investigate leakage lock bloodstream measuring , injection lock , evolution haemostasis test calcaemia . The finding complete safety data already collect VERROU REA study .</brief_summary>
	<brief_title>Biological Clinical Measurements Following Systemic Leakage When Citrate Heparin Lock Used</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Patient age &gt; 18 year Requiring dialysis acute kidney failure In first nontunnelled catheter insert In jugular femoral position Once inform consent obtain patient , family member person trust Patients active poorlycontrolled bleeding Known allergy citrate Liver failure ( Factor V &lt; 30 % ) Thrombopenia &lt; 30 000/mm3 absence plan corrective measure time randomization Known suspect heparininduced thrombopenia Positive blood culture without treatment inappropriate treatment time randomization Catheter insert subclavian position Person without national health insurance cover Pregnant woman Adults guardianship</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>patient</keyword>
</DOC>